Aller au contenu principal
Profil bibliographique

Brenda Bacelar

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

6Publications signalées
6Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

COVID-19 Clinical Research StudiesHIV/AIDS Research and InterventionsHIV/AIDS drug development and treatmentHIV-related health complications and treatmentsSARS-CoV-2 and COVID-19 Research

Les publications récentes

Accès ouvert 2026 article OpenAlex

Long-term persistence, effectiveness, safety, and metabolic impact of bictegravir/emtricitabine/tenofovir alafenamide fixed-dose combination in people living with HIV in the BICTARG cohort

Diego Cecchini, Martín Brizuela, Gastón Copertari, Brenda Bacelar et autres

INTRODUCTION: Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) is a preferred antiretroviral regimen in international guidelines, but long-term real-world data in Latin American people living with HIV (PLWH) are scarce. This study describes 48-month persistence, virological effectiveness, safety and metabolic changes in the Argentine BICTARG cohort. …

ar (code pays fourni par la source)

0 citations Revista Española de Quimioterapia
Accès ouvert 2025 article OpenAlex

Effectiveness and safety of dual therapy with co-packaged dolutegravir and lamivudine compared to triple therapy as switching strategy in clinical practice

Diego Cecchini, Edgardo Bottaro, Brenda Bacelar, Ángeles Tisné et autres

INTRODUCTION: Dolutegravir plus lamivudine (DTG/3TC) dual therapy has demonstrated efficacy in HIV treatment, but access remains challenging in Latin America. Argentina approved a generic co-packaged DTG+3TC presentation to improve accessibility. This study evaluated the effectiveness and safety of co-packed DTG/3TC compared to …

ar (code pays fourni par la source)

0 citations Revista Española de Quimioterapia
2025 article OpenAlex

Bictegravir/emtricitabine/tenofovir alafenamide fixed-dose combination in advanced HIV disease.

Diego Cecchini, C. Serrano, Martín Brizuela, Gastón Copertari et autres

INTRODUCTION: Real-world data on bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) showed high virologic suppression (VS) in treatment-naive (TN) and experienced (TE) people living with HIV (PLWH). The BIC-CD4 study aims to describe safety, persistence, and VS in PLWH who started B/F/TAF with CD4 <200/mm3, representing …

ar, co (code pays fourni par la source)

0 citations PubMed
2023 article OpenAlex

[Comparative analysis of clinical characteristics, evolution and mortality of hospitalized patients with COVID-19 during the first and second wave of the pandemic (ECCOVID Study)].

Ezequiel Córdova, Analía Mykietiuk, Lautaro De Vedia, Brenda Bacelar et autres

INTRODUCTION: Clinical features and outcomes of SARSCoV-2 infections may change between different waves of the pandemic. The objective of this study was to compare clinical characteristics and outcomes between two cohorts of patients hospitalized for COVID-19 during the first and second waves …

ar, us (code pays fourni par la source)

0 citations PubMed

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.